Results 1 to 10 of about 706 (50)

Highlight selection of radiochemistry and radiopharmacy developments by editorial board [PDF]

EJNMMI Radiopharmacy and Chemistry
Background The Editorial Board of EJNMMI Radiopharmacy and Chemistry releases a biannual highlight commentary to update the readership on trends in the field of radiopharmaceutical development.
Jun Toyohara, Danielle Vugts, Oliver C. Kiss, Sergio Todde, Xiang-Guo Li, Zhibo Liu, Zhi Yang, Nic Gillings, Emiliano Cazzola, Wiktor Szymanski, Nick van der Meulen, Raymond Reilly, Carlotta Taddei, Ralf Schirrmacher, Zijing Li, Yohannes Jorge Lagebo, Naoual Bentaleb, Marta de Souza Albernaz, Suzanne Lapi, Caterina Ramogida, Archana Mukherjee, Javier Ajenjo, Winnie Deuther-Conrad, Cécile Bourdeau   +23 more
doaj   +5 more sources

Proceedings of international symposium of trends in radiopharmaceuticals 2023 (ISTR-2023) [PDF]

EJNMMI Radiopharmacy and Chemistry, 2023
The International Atomic Energy Agency (IAEA) held the 3rd International Symposium on Trends in Radiopharmaceuticals, (ISTR-2023) at IAEA Headquarters in Vienna, Austria, during the week of 16–21 April 2023.
Amirreza Jalilian, Clemens Decristoforo, Melissa Denecke, Philip H. Elsinga, Cornelia Hoehr, Aruna Korde, Suzanne E. Lapi, Peter J. H. Scott   +7 more
doaj   +2 more sources

Trends in nuclear medicine and the radiopharmaceutical sciences in oncology: workforce challenges and training in the age of theranostics [PDF]

The Lancet Oncology
Although the promise of radionuclides for the diagnosis and treatment of disease was recognised soon after the discovery of radioactivity in the late 19th century, the systematic use of radionuclides in medicine only gradually increased over the subsequent hundred years.
Andrew M, Scott, Brian M, Zeglis, Suzanne E, Lapi, Peter J H, Scott, Albert D, Windhorst, May, Abdel-Wahab, Francesco, Giammarile, Diana, Piaez, Amirreza, Jalilian, Peter, Knoll, Aruna, Korde, Shrikant, Vichare, Nayyereh, Ayati, Sze Ting, Lee, Serge K, Lyashchenko, Jingjing, Zhang, Jean Luc, Urbain, Jason S, Lewis   +17 more
openaire   +3 more sources

Highlight selection of radiochemistry and radiopharmacy developments by editorial board

EJNMMI Radiopharmacy and Chemistry, 2023
Background The Editorial Board of EJNMMI Radiopharmacy and Chemistry releases a biannual highlight commentary to update the readership on trends in the field of radiopharmaceutical development.
Jean DaSilva, Clemens Decristoforo, Robert H. Mach, Guy Bormans, Giuseppe Carlucci, Mohammed Al-Qahtani, Adriano Duatti, Antony D. Gee, Wiktor Szymanski, Sietske Rubow, Jeroen Hendrikx, Xing Yang, Hongmei Jia, Junbo Zhang, Peter Caravan, Hua Yang, Jan Rijn Zeevaart, Miguel Avila Rodriquez, Ralph Santos Oliveira, Marcela Zubillaga, Tamer Sakr, Sarah Spreckelmeyer   +21 more
doaj   +2 more sources

Highlight selection of radiochemistry and radiopharmacy developments by editorial board

EJNMMI Radiopharmacy and Chemistry, 2022
Background The Editorial Board of EJNMMI Radiopharmacy and Chemistry releases a biannual highlight commentary to update the readership on trends in the field of radiopharmaceutical development.
Jun Toyohara, Mohammed Al-Qahtani, Ya-Yao Huang, Emiliano Cazzola, Sergio Todde, Shozo Furumoto, Renata Mikolajczak, Clemens Decristoforo, Nic Gillings, Min Yang, Raymond Reilly, Adriano Duatti, Antonia Denkova, Ralf Schirrmacher, Giuseppe Carlucci, Yann Seimbille, Zhaofei Liu, Beverley Ellis, Bart T. Cornelissen, Klaus Kopka, Emerson Bernardes   +20 more
doaj   +1 more source

Trends in nuclear medicine and the radiopharmaceutical sciences in oncology

lancet oncology
Although the promise of radionuclides for the diagnosis and treatment of disease was recognised soon after the discovery of radioactivity in the late 19th century, the systematic use of radionuclides in medicine only gradually increased over the subsequent hundred years.
Scott, Andrew M., Zeglis, Brian M., Lapi, Suzanne E., Scott, Peter J. H., Windhorst, Albert D., Abdel-Wahab, May, Giammarile, Francesco, Piaez, Diana, Jalilian, Amirreza, Knoll, Peter, Korde, Aruna, Vichare, Shrikant, Ayati, Nayyereh, Lee, Sze Ting, Lyashchenko, Serge K., Zhang, Jingjing, Urbain, Jean Luc, Lewis, Jason S.   +17 more
openaire   +1 more source

Challenges in radiopharmaceutical importation across six Southern African Development Community countries: an exploratory study. [PDF]

Front Med (Lausanne)
Mkhombo VG, Mosima L, Summers B.
europepmc   +1 more source

Population pharmacokinetic modeling in radiopharmaceutical therapy: a review. [PDF]

Front Nucl Med
Hardiansyah D, Patrianesha BB, Glatting G.   +2 more
europepmc   +1 more source

Strategic Objectives of Nanotechnology-Driven Repurposing in Radiopharmacy-Implications for Radiopharmaceutical Repurposing (Beyond Oncology). [PDF]

Pharmaceutics
Salgueiro MJ, Zubillaga M.
europepmc   +1 more source

Fluorination augments tumor engagement and antitumor immunity of a D-peptide-based radiotheranostic agent for combinatorial immune checkpoint blockade therapy. [PDF]

J Immunother Cancer
Zhang S, Liu C, Lu Q, Liu W, Wu J, Liu J, Tong L, Zhao K, Hu Q, Chen X, Li L, Song X, Wang F, Dai D, Wang R, Hu K.   +15 more
europepmc   +1 more source